Bo Liang PhD, MBA
Chairman And Chief Executive Officer
Dr. Bo Liang is a serial entrepreneur with over 20 years of experience in drug discovery research, chemical and material sciences, biotechnology and materials venture and management. Dr. Liang is Co-Founder, Chairman and CEO of IVIEW Therapeutics Inc. a clinical stage biotechnology company focusing on innovative ophthalmic therapeutics. We invest in novel mechanisms of action, and drug delivery technology platforms that allow us to bring forward differentiated assets with potentially superior target product profiles. The company's innovative product pipeline spans over dry eye, acute conjunctivitis, myopia, presbyopia and novel ocular gene therapies. Lead programs to treat dry eye and acute conjunctivitis are in phase II clinical trials for late-stage development. Dr. Liang was also co-founder and Chairman of Adesso Advanced Materials, which developed revolutionary degradable curing agents and recyclable epoxy resin systems for next-generation sustainable carbon fiber composites.
Dr. Liang co-founded CLS Pharmaceuticals in New York city with ophthalmologists in 2006, and advanced an ophthalmic drug project into clinical phase II stage to treat viral conjunctivitis and then co-founded Foresight Biotherapeutics, Inc. with a New York venture capital firm to advance the program. The program was acquired by Shire Pharmaceuticals in 2015 after completion of successful phase II trials. Soon after his exit from the first venture, he co-founded IVIEW Therapeutics Inc. Dr. Liang was previously Senior Scientist at Pharmacopeia, Inc. in New Jersey for six years, leading medicinal chemistry development of first-in-class small molecule therapeutics for respiratory and CNS diseases.
Dr. Liang holds over 50 issued international patents and patent applications. He was a reviewer for Journal of Bioorganic and Medicinal Chemistry. Dr. Liang is Co-Founder of Sino-American Pharmaceutical Professionals Association-Greater Philadelphia (SAPA-GP) and served as the first President of SAPA-GP from 2002 to 2004. Dr. Liang obtained his PhD in chemistry from the University of Pennsylvania, MBA from the Stern School of Business of NYU, and Bachelor of chemistry from Peking University in China.
语言：